Who owns ELEDON PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Eledon Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Eledon Pharmaceuticals stock

Who bought or sold ELEDON PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
BVF 4.3M $7.8M 0% Dec 2023
 View chart
Vanguard Group 695k $1.3M 3% Dec 2023
 View chart
CM Management 140k $252k -40% Dec 2023
 View chart
Jmac Enterprises 58k $105k 0% Dec 2023
 View chart
Ingalls & Snyder 52k $93k 0% Dec 2023
 View chart
Citadel Advisors 24k $43k 100% Dec 2023
 View chart
Millennium Management 23k $41k -16% Dec 2023
 View chart
Mercer Global Advisors 17k $30k 0% Dec 2023
 View chart
Charles Schwab Investment Management 15k $27k 0% Dec 2023
 View chart
Pathstone Holdings 13k $24k 100% Dec 2023
 View chart
Two Sigma Securities 12k $21k 100% Dec 2023
 View chart
Simplex Trading 3.2k $5.0k -11% Dec 2023
 View chart
Jpmorgan Chase & Co 990.00 $1.8k 3708% Dec 2023
 View chart
UBS Group 556.00 $973.000000 100% Dec 2023
 View chart
Wells Fargo & Company 186.00 $335.004600 8% Dec 2023
 View chart
Royal Bank of Canada 108.00 $0 -100% Dec 2023
 View chart
Bank of America Corporation 15.00 $27.000000 100% Dec 2023
 View chart

Who sold out of Eledon Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Two Sigma Advisers Sep 2023 13k $18k
RMB Capital Management Sep 2023 10k $14k